While headlines warn that AI could unleash future biological threats, the technology also offers our best defense: a way to anticipate viral evolution and stress-test treatments. Rather than waiting ...

Since the start of the SARS-CoV-2 pandemic, several variants of the virus have developed into Variants of Concern (VOCs), as classified by the World Health Organization (WHO). VOCs are virus variants ...

The Global Virus Network (GVN), representing eminent human and animal virologists from more than 90 Centers of Excellence and Affiliates in over 40 countries dedicated to advancing research, ...

The FDA approved updated 2026-2027 COVID-19 vaccines from Pfizer and BioNTech, Moderna, Sanofi, and Takeda within a 2-day span during August 2026, clearing 3 reformulated immunizations that target the ...

Viral infectious diseases pose significant challenges due to the rapid evolution of viruses through mutations. This was particularly evident during the COVID-19 pandemic, when emerging variants of ...

The FDA approved an updated round of COVD-19 vaccines for the 2026-2027 respiratory disease season that target circulating ...

Findings suggest that SARS-CoV-2 infection can activate an immune program that closely resembles those involved in ...

The SARS-CoV-2 variant BA.3.2 spread slowly before being detected in at least 23 countries in five continents by February. The prevalence of BA.3.2 was 0.55% among 5,238 U.S. samples collected from ...

The Global Virus Network (GVN) is closely monitoring the emergence of a newly identified SARS-CoV-2 variant, NB.1.8.1, a sublineage of the Omicron family. This variant was first identified in January ...

Objectives Observational studies suggest that acid suppression may worsen outcomes among patients infected with SARS-CoV-2. The objectives of this embedded substudy of a randomised controlled trial ...